{"id":45661,"date":"2022-06-29T22:01:35","date_gmt":"2022-06-29T20:01:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/"},"modified":"2022-06-29T22:01:35","modified_gmt":"2022-06-29T20:01:35","slug":"duality-quantum-accelerator-announces-startups-selected-for-cohort-2","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/","title":{"rendered":"Duality Quantum Accelerator Announces Startups Selected for Cohort 2"},"content":{"rendered":"<div>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/quantum?src=hash\" target=\"_blank\" rel=\"noopener\">#quantum<\/a>&#8211;Duality, the nation\u2019s first accelerator exclusively for quantum companies, has accepted five startups from across the globe into the second cohort of the year-long accelerator based in Chicago, IL.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/5\/Duality_Logo_Tagline_Color_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg\"><\/a><\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dualityaccelerator.com%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=Duality&amp;index=1&amp;md5=53ceab1baf7131a2ce38f4c8d0c82ca9\" rel=\"nofollow noopener\" shape=\"rect\">Duality<\/a> is led by the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpolsky.uchicago.edu%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=Polsky+Center+for+Entrepreneurship+and+Innovation&amp;index=2&amp;md5=c7bf25a0cedf15eb3e2d45b2b1b2642c\" rel=\"nofollow noopener\" shape=\"rect\">Polsky Center for Entrepreneurship and Innovation<\/a> at the University of Chicago and the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fquantum.uchicago.edu%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=Chicago+Quantum+Exchange+%28CQE%29&amp;index=3&amp;md5=6456d8ca0752bdbd94d01f7c066bedf6\" rel=\"nofollow noopener\" shape=\"rect\">Chicago Quantum Exchange (CQE)<\/a>, along with founding partners, the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fillinois.edu%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=University+of+Illinois+Urbana-Champaign&amp;index=4&amp;md5=2d88fcb89efa511e750469a256837340\" rel=\"nofollow noopener\" shape=\"rect\">University of Illinois Urbana-Champaign<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.anl.gov%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=Argonne+National+Laboratory&amp;index=5&amp;md5=89a5e8205c65ac2b6d2b9736ef9503ce\" rel=\"nofollow noopener\" shape=\"rect\">Argonne National Laboratory<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fp33chicago.com%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=P33&amp;index=6&amp;md5=37f25491ddc4c1fec3e9e449138b9042\" rel=\"nofollow noopener\" shape=\"rect\">P33<\/a>.\n<\/p>\n<p>\n\u201cIllinois is proud to welcome the second cohort of quantum startups to the nation\u2019s preeminent research corridor in the field, yet another testament to the University of Chicago and the University of Illinois\u2019 leadership in this sector,\u201d said Governor JB Pritzker<b>.<\/b> \u201cQuantum will be the defining feature of the 21<sup>st<\/sup> century\u2019s technological advancements, and I\u2019ve directed $200 million in state funding to facilitate Illinois\u2019 global leadership in the quantum race. I want to also thank our powerhouse universities as well as our national laboratories and private sector partners for making that leadership possible \u2013 as demonstrated by Duality\u2019s first cohort, the success is only beginning.\u201d\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.uchicago.edu%2Fstory%2Fquantum-startup-accelerator-duality-polsky-center-chicago-quantum-exchange&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=Launched+in+April+2021&amp;index=7&amp;md5=0541643106918c8282e99df2187c74eb\" rel=\"nofollow noopener\" shape=\"rect\">Launched in April 2021<\/a>, Duality is a first-of-its-kind accelerator aimed at supporting next-generation startups focused on quantum science and technology. The 12-month program provides world-class business and entrepreneurship training from its partner institutions and the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.chicagobooth.edu%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=University+of+Chicago+Booth+School+of+Business&amp;index=8&amp;md5=b118a57aa4213a5fad31c5bc5d4f4922\" rel=\"nofollow noopener\" shape=\"rect\">University of Chicago Booth School of Business<\/a>.\n<\/p>\n<p>\nDuality Cohort 1 startups have secured <b>more than $8.5 million<\/b> in funding; grew from an average of 4.3 employees before starting the program to an average of 7.6, with exponential growth expected by many within the next two years. <b>All of the startups will maintain a presence in Chicago.<\/b>\n<\/p>\n<p>\n\u201cThe inaugural cohort has seen incredible growth and connected with dozens of mentors, building relationships that have led to several new business opportunities. We are excited to build off this momentum with the selection of five new startups developing quantum technologies across a range of applications,\u201d said Eric Ginsburg, interim director of Duality and senior director, intellectual property and technology development at the Polsky Center.\n<\/p>\n<p>\n<b>Duality Cohort 2:<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Icosa Computing \/\/ <\/b>A US-based startup building quantum computing and physics enhanced optimizers for financial institutions\n<\/li>\n<li>\n<b>memQ \/\/<\/b> A US-based startup building components the quantum internet\n<\/li>\n<li>\n<b>QuantFi USA \/\/ <\/b>A France and US-based quantum computing software startup that has created a quantum emulator platform\n<\/li>\n<li>\n<b>SCALINQ \/\/<\/b> A Sweden-based startup developing unique packaging solutions for superconducting quantum chips\n<\/li>\n<li>\n<b>Wave Photonics \/\/<\/b> A UK-based startup using computational techniques to accelerate integrated photonics design\n<\/li>\n<\/ul>\n<p>\nThe selected ventures were chosen from a competitive pool of applicants from across the globe, vetted by an internal review process, and approved by Duality\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dualityaccelerator.com%2Fabout%2Fgoverning-board%2F&amp;esheet=52766311&amp;newsitemid=20220629005907&amp;lan=en-US&amp;anchor=Governing+Board&amp;index=9&amp;md5=a4b319ddf6c9dcd886308d753ff87c6b\" rel=\"nofollow noopener\" shape=\"rect\">Governing Board<\/a>.\n<\/p>\n<p>\n\u201cWe\u2019re at such an exciting moment in the development of quantum technologies, and the breadth of startup companies in the second cohort underscores the state\u2019s global draw as a hotbed of quantum innovation,\u201d said Susan Martinis, vice chancellor for research and innovation at the University of Illinois Urbana-Champaign. \u201cFrom homegrown ventures to European startups, we\u2019re building a quantum-powered future in Illinois\u2014and the world is taking note.\u201d\n<\/p>\n<p>\nThrough Duality, each startup will receive $50,000 in unrestricted funding and mentorship from top quantum experts. Selected startups will have the opportunity to explore partnerships and access to some of the region\u2019s state-of-the-art equipment and facilities for advanced computing, nanofabrication, atomic scale measurement, quantum testbeds, and other premier resources.\n<\/p>\n<p>\n\u201cIt\u2019s exciting to see the Chicago region driving the future of quantum information science and engineering,\u201d said Paul Kearns, director of the U.S. Department of Energy\u2019s Argonne National Laboratory, a founding partner in Duality. \u201cOur scientific leadership is providing early-stage startups the expertise and facilities they need to bring transformative quantum innovations to market. Together, we are accelerating science and technology for U.S. prosperity and security.\u201d\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlexia Elejalde-Ruiz<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x61;&#x6c;&#x65;&#120;&#105;a&#46;&#x65;&#x6c;&#x65;&#106;&#97;ld&#x65;&#x2d;&#x72;&#117;&#105;z&#64;&#x63;&#x68;&#x69;&#99;&#97;go&#x62;&#x6f;&#x6f;&#116;&#104;&#46;e&#x64;&#x75;\" rel=\"nofollow noopener\" shape=\"rect\">a&#108;&#x65;&#x78;i&#97;&#46;&#x65;&#x6c;e&#106;&#x61;&#x6c;d&#101;&#45;&#x72;&#x75;i&#122;&#x40;&#x63;h&#105;&#99;&#x61;&#x67;o&#98;&#x6f;&#x6f;t&#104;&#46;&#x65;&#x64;u<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;#quantum&#8211;Duality, the nation\u2019s first accelerator exclusively for quantum companies, has accepted five startups from across the globe into the second cohort of the year-long accelerator based in Chicago, IL. Duality is led by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago and the Chicago Quantum Exchange (CQE), along with founding &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45661","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Duality Quantum Accelerator Announces Startups Selected for Cohort 2 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Duality Quantum Accelerator Announces Startups Selected for Cohort 2 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;#quantum&#8211;Duality, the nation\u2019s first accelerator exclusively for quantum companies, has accepted five startups from across the globe into the second cohort of the year-long accelerator based in Chicago, IL. Duality is led by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago and the Chicago Quantum Exchange (CQE), along with founding ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-29T20:01:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Duality Quantum Accelerator Announces Startups Selected for Cohort 2\",\"datePublished\":\"2022-06-29T20:01:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/\"},\"wordCount\":628,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005907\\\/en\\\/1501375\\\/21\\\/Duality_Logo_Tagline_Color_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/\",\"name\":\"Duality Quantum Accelerator Announces Startups Selected for Cohort 2 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005907\\\/en\\\/1501375\\\/21\\\/Duality_Logo_Tagline_Color_RGB.jpg\",\"datePublished\":\"2022-06-29T20:01:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005907\\\/en\\\/1501375\\\/21\\\/Duality_Logo_Tagline_Color_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005907\\\/en\\\/1501375\\\/21\\\/Duality_Logo_Tagline_Color_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Duality Quantum Accelerator Announces Startups Selected for Cohort 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Duality Quantum Accelerator Announces Startups Selected for Cohort 2 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/","og_locale":"en_US","og_type":"article","og_title":"Duality Quantum Accelerator Announces Startups Selected for Cohort 2 - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;#quantum&#8211;Duality, the nation\u2019s first accelerator exclusively for quantum companies, has accepted five startups from across the globe into the second cohort of the year-long accelerator based in Chicago, IL. Duality is led by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago and the Chicago Quantum Exchange (CQE), along with founding ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-29T20:01:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Duality Quantum Accelerator Announces Startups Selected for Cohort 2","datePublished":"2022-06-29T20:01:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/"},"wordCount":628,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/","url":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/","name":"Duality Quantum Accelerator Announces Startups Selected for Cohort 2 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg","datePublished":"2022-06-29T20:01:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220629005907\/en\/1501375\/21\/Duality_Logo_Tagline_Color_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/duality-quantum-accelerator-announces-startups-selected-for-cohort-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Duality Quantum Accelerator Announces Startups Selected for Cohort 2"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45661"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45661\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}